KPX Lifescience.Co.Ltd Cash Flow Quality Index
KPX Lifescience.Co.Ltd cash flow quality index. KPX Lifescience.Co.Ltd (114450) has a Cash Flow Quality Index of 6.79x as of September 2025. Operating cash flow of ₩3.33 Billion exceeds net income of ₩490.19 Million, indicating high earnings quality where cash backs reported profits. See KPX Lifescience.Co.Ltd financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of KPX Lifescience.Co.Ltd (2015–2024)
Cash flow quality index of KPX Lifescience.Co.Ltd from 2015 to 2024. Historical Cash Flow Quality Index for KPX Lifescience.Co.Ltd across 5 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore how well can KPX Lifescience.Co.Ltd service its debt to assess how comfortably operating cash covers total debt obligations.
KPX Lifescience.Co.Ltd Cash Flow Quality Index by Year (2015–2024)
KPX Lifescience.Co.Ltd cash flow quality index by year from 2015 to 2024. Year-by-year earnings quality comparison for KPX Lifescience.Co.Ltd. For the full cash flow conversion analysis, see cash flow conversion of KPX Lifescience.Co.Ltd.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 0.34x | ₩525.49 Million | ₩1.56 Billion | ▼ -90.5% |
| 2019 | 3.55x | ₩4.24 Billion | ₩1.20 Billion | ▲ +38.9% |
| 2017 | 2.55x | ₩5.68 Billion | ₩2.22 Billion | ▲ +62.8% |
| 2016 | 1.57x | ₩7.07 Billion | ₩4.50 Billion | ▲ +50.5% |
| 2015 | 1.04x | ₩5.62 Billion | ₩5.39 Billion | — |